(Q53360218)

13 May 2018

title

CD44 is an independent prognostic factor in early-stage cervical cancer. (English)

1 reference

13 May 2018

main subject

cervix uterine cancer

1 reference

P Speiser

1

1 reference

13 May 2018

C Wanner

2

1 reference

13 May 2018

C Tempfer

3

1 reference

13 May 2018

M Mittelböck

4

1 reference

13 May 2018

E Hanzal

5

1 reference

13 May 2018

D Bancher-Todesca

6

1 reference

13 May 2018

G Gitsch

7

1 reference

13 May 2018

A Reinthaller

8

1 reference

13 May 2018

C Kainz

9

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

13 May 2018

International Journal of Cancer

published in

1 reference

13 May 2018

volume

74

1 reference

13 May 2018

page(s)

185-188

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

CD44 splice variants: metastases meet lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Differential CD44 expression patterns in primary brain tumours and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Alternative splicing in the control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Prognostic factors and operative treatment of stages IB to IIB cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Splice variants of CD44 in human cervical cancer stage IB to IIB

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Prognostic value of CD44 splice variants in human stage III cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Serum CD44 splice variants in cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

CD44 variant exon epitopes in primary breast cancer and length of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Significance of CD44 gene products for cancer diagnosis and disease evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970422%2974%3A2%3C185%3A%3AAID-IJC8%3E3.0.CO%3B2-V

10.1002/(SICI)1097-0215(19970422)74:2<185::AID-IJC8>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

9133453

1 reference

13 May 2018